Photodynamic Therapy With Verteporfin and Intravitreal Triamcinolone Acetonide in the Treatment of Neovascular Age-related Macular Degeneration
To access this article, please choose from the options below
Supported in part by an unrestricted Scientific Financial Grant by Novartis AG (Basel, Switzerland).
PII: S0002-9394(06)00343-6
doi:10.1016/j.ajo.2006.02.048
© 2006 Elsevier Inc. All rights reserved.
